Design and synthesis of new benzimidazole–Schiff base hybrids as highly potent in vitro α-glucosidase inhibitors

In this study, we synthesized some new benzimidazole–Schiff base hybrids ( 5a–5k ) and characterized them using nuclear magnetic resonance (NMR) and mass spectral methods. The in vitro α-glucosidase inhibitory activities of compounds 5a–5k were investigated. Notably, all compounds ( 5a–5k ) exhibited higher inhibition (IC 50 = 0.52–14.65 µM) than the standard drug acarbose (IC 50 = 45.3 µM), highlighting their significant α-glucosidase inhibitory potential. Within the series, compound 5i demonstrated the greatest activity with the lowest IC 50 value (0.52 µM), whereas 5k exhibited the lowest activity (IC 50 value of 14.65 µM). Molecular docking ( 5a–5k ) against Saccharomyces cerevisiae isomaltase (PDB: 3A4A) revealed favorable binding affinities, with docking scores ranging from −8.2 to −10.9 kcal/mol, exceeding that of acarbose (−8.8 kcal/mol) for several compounds. Compound 5i showed optimum binding affinity (−10.9 kcal/mol), forming several π–π, π–alkyl, π–anion, and H-bonds containing significant catalytic residues. Compounds 5e , 5h , and 5j demonstrated significant binding due to the substantial hydrophobic and electrostatic interactions inside the enzyme active site. Steady-state kinetic studies revealed that compound 5i is a potent competitive inhibitor of α-glucosidase, as shown by the Lineweaver–Burk plots displaying a common intercept with unchanged Vmax and improved apparent K m values. The secondary plot gave a K i value of 5.0 µM, representing the robust binding affinity of 5i toward free enzyme and higher affinity as related to the native PNPG substrate.

Authors

Institutions

Publication Details

Journal
Frontiers in Chemistry
Published
2026-11-18
DOI
https://doi.org/10.3389/fchem.2026.1941381
Primary Topic
Heterocyclic Compound Synthesis and Bioactivity
Type
article
Field-Weighted Citation Impact
0.00
Controls
|||
ALL TIME
JAN
FEB
MAR
APR
MAY
JUN
JUL
AUG
SEP
OCT
NOV
article

Design and synthesis of new benzimidazole–Schiff base hybrids as highly potent in vitro α-glucosidase inhibitors

Tella Lakshmi Viveka, THIRUKOVELA NARASIMHA SWAMY, Kusuma Tummala, Bathula Sreenu
Frontiers in Chemistry
Heterocyclic Compound Synthesis and Bioactivity
article

Design and synthesis of new benzimidazole–Schiff base hybrids as highly potent in vitro α-glucosidase inhibitors

Tella Lakshmi Viveka, THIRUKOVELA NARASIMHA SWAMY, Kusuma Tummala, Bathula Sreenu
article en

Abstract

In this study, we synthesized some new benzimidazole–Schiff base hybrids ( 5a–5k ) and characterized them using nuclear magnetic resonance (NMR) and mass spectral methods. The in vitro α-glucosidase inhibitory activities of compounds 5a–5k were investigated. Notably, all compounds ( 5a–5k ) exhibited higher inhibition (IC 50 = 0.52–14.65 µM) than the standard drug acarbose (IC 50 = 45.3 µM), highlighting their significant α-glucosidase inhibitory potential. Within the series, compound 5i demonstrated the greatest activity with the lowest IC 50 value (0.52 µM), whereas 5k exhibited the lowest activity (IC 50 value of 14.65 µM). Molecular docking ( 5a–5k ) against Saccharomyces cerevisiae isomaltase (PDB: 3A4A) revealed favorable binding affinities, with docking scores ranging from −8.2 to −10.9 kcal/mol, exceeding that of acarbose (−8.8 kcal/mol) for several compounds. Compound 5i showed optimum binding affinity (−10.9 kcal/mol), forming several π–π, π–alkyl, π–anion, and H-bonds containing significant catalytic residues. Compounds 5e , 5h , and 5j demonstrated significant binding due to the substantial hydrophobic and electrostatic interactions inside the enzyme active site. Steady-state kinetic studies revealed that compound 5i is a potent competitive inhibitor of α-glucosidase, as shown by the Lineweaver–Burk plots displaying a common intercept with unchanged Vmax and improved apparent K m values. The secondary plot gave a K i value of 5.0 µM, representing the robust binding affinity of 5i toward free enzyme and higher affinity as related to the native PNPG substrate.

Frontiers in ChemistryVol. 14
Chaitanya (IN)
Good health and well-being
Heterocyclic Compound Synthesis and Bioactivity
AI Navigator

Ask Laika to Summarize, Analyze, and Connect papers live on the map.

Summarize Papers & Methodologies

Extract key findings, datasets, and comparative methods across publications.

Benchmark Rankings & Visual Analytics

Rank top research institutions, authors, funders, topics, and journals by Field-Weighted Citation Impact (FWCI) and paper volume with instant charts.

Connect Distant Disciplines

Bridge topological clusters on the map to find hidden collaborative intersections.

Laika access coming soon